HomeStocksAKTS

AKTS — structural market context

Aktis Oncology, Inc. Common st

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

AKTS short interest & days to cover

SHARES SHORT
3.5M
% OF FLOAT
DAYS TO COVER
12.8
CHANGE VS PRIOR
-7.2%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-07-31 (19d ago)

AKTS fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-07-30 · 20d5K$22.39
2026-07-28 · 22d653$24.21
2026-07-27 · 23d2K$23.89

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

AKTS analyst ratings — with each firm's measured accuracy

FirmActionRatingFirm 5d hit rate*Published
WedbushinitialiseOutperform46.1% (n=165)2026-08-19
Wedbushprice_target46.1% (n=165)2026-08-19
BMO Capitalprice_targetn<302026-08-18
BMO CapitalinitialiseOutperformn<302026-08-18

*Rating actions from public feeds. Where shown, the firm's 5-day hit rate is our measured backtest (firms with >=30 graded calls); a historical hit rate describes past calls, it does not grade this one.

Frequently asked questions

What do analysts say about AKTS?
The most recent action: Wedbush initialise to Outperform on 2026-08-19. In our backtest, Wedbush's 5-day hit rate across 165 graded calls is 46.1%. We show each firm's measured record next to its ratings; a historical hit rate describes past calls and does not grade this one.
Is this page telling me to buy or sell AKTS?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerAnalyst Accuracy trackerThe platform

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.